Programmed Death Ligand-1 (PD-L1) Expression in Patients with Non-Small Cell Lung Cancer (NSCLC) with Unusual Metastasis: A Case Series

被引：0
|
作者：
Tsugitomi, R. [1 ]
Nishimura, N. [1 ]
Imai, R. [1 ]
Okafuji, K. [1 ]
Kitamura, A. [1 ]
Tomishima, Y. [1 ]
Jinta, T. [1 ]
Suzuki, K. [2 ]
Tamura, T. [1 ]
机构：
[1] St Lukes Int Hosp, Dept Pulm Med, Thorac Ctr, Tokyo, Japan
[2] St Lukes Int Hosp, Dept Pathol, Tokyo, Japan
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3940
引用
收藏
页数：2
相关论文
共 50 条
  • [41] PD-L1 expression and survival in patients with non-small cell lung cancer (NSCLC) in Korea
    Sun, Jong-Mu
    Zhou, Wei
    Choi, Yoon-La
    Choi, So-Jung
    Kim, Se Eun
    Wang, Zhen
    Dolled-Filhart, Marisa
    Emancipator, Kenneth
    Weiner, Russell
    Park, Minjin
    Kim, Hong Kwan
    Choi, Yong Soo
    Shim, Young Mog
    Kim, Jhingook
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [42] Prevalence of programmed cell death ligand 1 (PD-L1) Expression among Tumor Samples from Iraqi Patients with Non-Small Cell Lung Cancer
    Yahya, Alaa Qasim
    Alhamadani, Zina A. Rajab
    Ahmed, Samir Z.
    Hussain, Ahmad Fawzi
    ADVANCEMENTS IN LIFE SCIENCES, 2025, 12 (01): : 114 - 119
  • [43] PD-L1 Expression in Patients with Non-small Cell Lung Cancer
    Masago, Katsuhiro
    Fujita, Shiro
    Hata, Akito
    Okuda, Chiyuki
    Kaji, Reiko
    Katakami, Nobuyuki
    Hirata, Yukio
    ANTICANCER RESEARCH, 2017, 37 (05) : 2269 - 2274
  • [44] Programmed death ligand-1 (PD-L1) expression in penile squamous cell carcinoma
    Wang, Jennifer
    Rodriguez, Jaime
    Rao, Priya
    Pettaway, Curtis Alvin
    Pagliaro, Lance C.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [45] Immunohistochemical Scores for Programmed Death Ligand-1 (PD-L1) Expression and Prognostic in Patients with Gastric Cancer
    Pereira, Marina A.
    Ramos, Marcus Fernando Kodama P.
    Ribeiro e Ribeiro, Renan
    Dias, Andre R.
    Ribeiro, Ulysses, Jr.
    Zilberstein, Bruno
    Cecconello, Ivan
    Mello, Evandro Sobroza
    Castria, Tiago B.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2020, 231 (04) : E208 - E208
  • [46] Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Lorena Incorvaia
    Daniele Fanale
    Giuseppe Badalamenti
    Nadia Barraco
    Marco Bono
    Lidia Rita Corsini
    Antonio Galvano
    Valerio Gristina
    Angela Listì
    Salvatore Vieni
    Stefania Gori
    Viviana Bazan
    Antonio Russo
    Advances in Therapy, 2019, 36 : 2600 - 2617
  • [47] Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Incorvaia, Lorena
    Fanale, Daniele
    Badalamenti, Giuseppe
    Barraco, Nadia
    Bono, Marco
    Corsini, Lidia Rita
    Galvano, Antonio
    Gristina, Valerio
    Listi, Angela
    Vieni, Salvatore
    Gori, Stefania
    Bazan, Viviana
    Russo, Antonio
    ADVANCES IN THERAPY, 2019, 36 (10) : 2600 - 2617
  • [48] Clinicopathological and prognostic significance of programmed cell death ligand1 (PD-L1) expression in patients with non-small cell lung cancer: a meta-analysis
    Pan, Zhen-Kui
    Ye, Feng
    Wu, Xuan
    An, Han-Xiang
    Wu, Jing-Xun
    JOURNAL OF THORACIC DISEASE, 2015, 7 (03) : 462 - 470
  • [49] Correlation of Programmed Cell Death Ligand-1 Messenger RNA and Protein Expression in Non-Small Cell Lung Cancer
    Kwon, H. J.
    Kim, H.
    Park, S. Y.
    Park, E.
    Chung, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2243 - S2244
  • [50] Programmed death-ligand 1 (PD-L1) expression in non-small cell lung cancer (NSCLC) and correlation with clinical variables and other oncogenic drivers: An immunohistochemical analysis
    Singh, V.
    Jain, D.
    Malik, P. S.
    Kumar, S.
    EUROPEAN JOURNAL OF CANCER, 2016, 54 : S14 - S15
12345